Tackling cardiovascular disease in the Asia–Pacific region: a new Lancet Commission por Walter Suárez Carmona | Sep 1, 2025
Getting back on track to meet global anaemia reduction targets: a Lancet Haematology Commission por Walter Suárez Carmona | Sep 1, 2025
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial por Walter Suárez Carmona | Ago 25, 2025
Comparison of subcutaneous, visceral, liver and muscle fat depots in relation to prevalent and incident diabetes por Walter Suárez Carmona | Ago 20, 2025
